paroxetine has been researched along with eszopiclone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hotha, KK; Jagadeesh, B; Jaya Veera, KN; Ravindranath, LK; Venkateswarulu, V; Vijaya Bharathi, D | 1 |
1 review(s) available for paroxetine and eszopiclone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for paroxetine and eszopiclone
| Article | Year |
|---|---|
A rapid LC-MS/MS method for quantitation of eszopiclone in human plasma: application to a human pharmacokinetic study.
Topics: Azabicyclo Compounds; Chromatography, Liquid; Drug Stability; Eszopiclone; Humans; Linear Models; Male; Paroxetine; Piperazines; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |